OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
A Pandemic Lesson for Global Lung Diseases: Exacerbations Are Preventable
William Cookson, Miriam F. Moffatt, Garth Rapeport, et al.
American Journal of Respiratory and Critical Care Medicine (2022) Vol. 205, Iss. 11, pp. 1271-1280
Open Access | Times Cited: 30
William Cookson, Miriam F. Moffatt, Garth Rapeport, et al.
American Journal of Respiratory and Critical Care Medicine (2022) Vol. 205, Iss. 11, pp. 1271-1280
Open Access | Times Cited: 30
Showing 1-25 of 30 citing articles:
Lipid-Laden Macrophages in Pulmonary Diseases
Yin Zhu, Dooyoung Choi, Payaningal R. Somanath, et al.
Cells (2024) Vol. 13, Iss. 11, pp. 889-889
Open Access | Times Cited: 6
Yin Zhu, Dooyoung Choi, Payaningal R. Somanath, et al.
Cells (2024) Vol. 13, Iss. 11, pp. 889-889
Open Access | Times Cited: 6
Change in exacerbation rate of COPD patients before and after COVID-19 infection
Joon Young Choi, Kyung Joo Kim, Chin Kook Rhee
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Joon Young Choi, Kyung Joo Kim, Chin Kook Rhee
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Early Diagnosis of Pneumonia and Chronic Obstructive Pulmonary Disease with a Smart Stethoscope with Cloud Server-Embedded Machine Learning in the Post-COVID-19 Era
Direk Sueaseenak, Peeravit Boonsat, Suchada Tantisatirapong, et al.
Biomedicines (2025) Vol. 13, Iss. 2, pp. 354-354
Open Access
Direk Sueaseenak, Peeravit Boonsat, Suchada Tantisatirapong, et al.
Biomedicines (2025) Vol. 13, Iss. 2, pp. 354-354
Open Access
Changing Epidemiology of Pediatric Pulmonary Exacerbations in Cystic Fibrosis
Yaron Fireizen, Mohamoud Ahmed, Tim Vigers, et al.
Pediatric Pulmonology (2025) Vol. 60, Iss. 3
Closed Access
Yaron Fireizen, Mohamoud Ahmed, Tim Vigers, et al.
Pediatric Pulmonology (2025) Vol. 60, Iss. 3
Closed Access
Pan-antiviral effects of a PIKfyve inhibitor on respiratory virus infection in human nasal epithelium and mice
Jonathan Baker, Hugo Ombredane, Leah Daly, et al.
Antimicrobial Agents and Chemotherapy (2023) Vol. 68, Iss. 1
Open Access | Times Cited: 8
Jonathan Baker, Hugo Ombredane, Leah Daly, et al.
Antimicrobial Agents and Chemotherapy (2023) Vol. 68, Iss. 1
Open Access | Times Cited: 8
Genomic attributes of airway commensal bacteria and mucosa
Leah Cuthbertson, Ulrike Löber, Jonathan Ish-Horowicz, et al.
Communications Biology (2024) Vol. 7, Iss. 1
Open Access | Times Cited: 2
Leah Cuthbertson, Ulrike Löber, Jonathan Ish-Horowicz, et al.
Communications Biology (2024) Vol. 7, Iss. 1
Open Access | Times Cited: 2
Respiratory pathogen and clinical features of hospitalized patients in acute exacerbation of chronic obstructive pulmonary disease after COVID 19 pandemic
Soo Jung Kim, Taehee Kim, Hayoung Choi, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 2
Soo Jung Kim, Taehee Kim, Hayoung Choi, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 2
Population-level trends in asthma and chronic obstructive pulmonary disease emergency department visits and hospitalizations before and during the coronavirus disease 2019 pandemic in the United States
Adam Gaffney, David U. Himmelstein, Steffie Woolhandler
Annals of Allergy Asthma & Immunology (2023) Vol. 131, Iss. 6, pp. 737-744.e8
Closed Access | Times Cited: 7
Adam Gaffney, David U. Himmelstein, Steffie Woolhandler
Annals of Allergy Asthma & Immunology (2023) Vol. 131, Iss. 6, pp. 737-744.e8
Closed Access | Times Cited: 7
Predicting the RSV Surge: Pediatric RSV Patterns of the COVID Pandemic
Sidney Zven, Madeline Dorr, Allison M.W. Malloy, et al.
The Pediatric Infectious Disease Journal (2023) Vol. 42, Iss. 9, pp. e349-e351
Open Access | Times Cited: 6
Sidney Zven, Madeline Dorr, Allison M.W. Malloy, et al.
The Pediatric Infectious Disease Journal (2023) Vol. 42, Iss. 9, pp. e349-e351
Open Access | Times Cited: 6
Age-dependent rebound in asthma exacerbations after COVID-19 lockdown
Guy Hazan, Carolyn Fox, Huram Mok, et al.
Journal of Allergy and Clinical Immunology Global (2022) Vol. 1, Iss. 4, pp. 314-318
Open Access | Times Cited: 8
Guy Hazan, Carolyn Fox, Huram Mok, et al.
Journal of Allergy and Clinical Immunology Global (2022) Vol. 1, Iss. 4, pp. 314-318
Open Access | Times Cited: 8
Characterization and inhibition of inflammasome responses in severe and non-severe asthma
Jay C. Horvat, Richard Kim, Natasha Weaver, et al.
Respiratory Research (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 4
Jay C. Horvat, Richard Kim, Natasha Weaver, et al.
Respiratory Research (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 4
Disparities in Disease Burden and Treatment of Patients Asthma and Chronic Obstructive Pulmonary Disease
Adam Gaffney
Medical Clinics of North America (2022) Vol. 106, Iss. 6, pp. 1027-1039
Closed Access | Times Cited: 7
Adam Gaffney
Medical Clinics of North America (2022) Vol. 106, Iss. 6, pp. 1027-1039
Closed Access | Times Cited: 7
Do upper respiratory viruses contribute to racial and ethnic disparities in emergency department visits for asthma?
Darlene Bhavnani, Matthew Wilkinson, Rebecca Zárate, et al.
Journal of Allergy and Clinical Immunology (2022) Vol. 151, Iss. 3, pp. 778-782.e1
Open Access | Times Cited: 5
Darlene Bhavnani, Matthew Wilkinson, Rebecca Zárate, et al.
Journal of Allergy and Clinical Immunology (2022) Vol. 151, Iss. 3, pp. 778-782.e1
Open Access | Times Cited: 5
What trials do and do not tell us about treatments for severe asthma
Jennifer K Quint, Pallav L. Shah
The Lancet (2024) Vol. 403, Iss. 10423, pp. 224-226
Closed Access
Jennifer K Quint, Pallav L. Shah
The Lancet (2024) Vol. 403, Iss. 10423, pp. 224-226
Closed Access
Changes of respiratory pathogen and clinical features of in acute exacerbation of chronic obstructive pulmonary disease after COVID-19 pandemic
Soo Jung Kim, Taehee Kim, Hayoung Choi, et al.
Research Square (Research Square) (2024)
Open Access
Soo Jung Kim, Taehee Kim, Hayoung Choi, et al.
Research Square (Research Square) (2024)
Open Access
New Vaccines for Chronic Respiratory Patients
Narmeen Mallah, Ana Dacosta Urbieta, Irene Rivero‐Calle, et al.
Archivos de Bronconeumología (2024) Vol. 60, Iss. 9, pp. 565-575
Open Access
Narmeen Mallah, Ana Dacosta Urbieta, Irene Rivero‐Calle, et al.
Archivos de Bronconeumología (2024) Vol. 60, Iss. 9, pp. 565-575
Open Access
Application of Nanobiomedicine in Acute Lung Injury
Doudou Lei, B Wang, Mingjing Yin, et al.
Journal of Biomaterials and Tissue Engineering (2024) Vol. 14, Iss. 3, pp. 115-129
Closed Access
Doudou Lei, B Wang, Mingjing Yin, et al.
Journal of Biomaterials and Tissue Engineering (2024) Vol. 14, Iss. 3, pp. 115-129
Closed Access
Microbiome diversity, intra-mucosal bacteria and immune integration within normal and asthmatic airway mucosa
Miriam F. Moffatt, Tamiko Nishimura, Michael J. Cox, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Miriam F. Moffatt, Tamiko Nishimura, Michael J. Cox, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Triple Therapy in COPD in Real Life: Is It Better to Use Single or Multiple Inhalers?
Bruno Sposato, Alberto Rícci, Leonardo Gianluca Lacerenza, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 20, pp. 6191-6191
Open Access
Bruno Sposato, Alberto Rícci, Leonardo Gianluca Lacerenza, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 20, pp. 6191-6191
Open Access
Respiratory pathogen trends in queensland, australia between 2018 and 2021: A statewide cohort study before and after the initial COVID-19 outbreak
Amy Sweeny, John Gerrard, Kylie Alcorn, et al.
Archives of Medical Research (2024) Vol. 56, Iss. 3, pp. 103144-103144
Open Access
Amy Sweeny, John Gerrard, Kylie Alcorn, et al.
Archives of Medical Research (2024) Vol. 56, Iss. 3, pp. 103144-103144
Open Access
Exacerbations of COPD
Brian Carlin
Respiratory Care (2023) Vol. 68, Iss. 7, pp. 961-972
Closed Access | Times Cited: 1
Brian Carlin
Respiratory Care (2023) Vol. 68, Iss. 7, pp. 961-972
Closed Access | Times Cited: 1
Characteristics of 12-Month Readmission for Hospitalized Patients with COPD: A Propensity Score Matched Analysis of Prospective Multicenter Study
Tingting Xu, Wei Sun, Hongqing Zhao, et al.
International Journal of COPD (2022) Vol. Volume 17, pp. 2329-2341
Open Access | Times Cited: 2
Tingting Xu, Wei Sun, Hongqing Zhao, et al.
International Journal of COPD (2022) Vol. Volume 17, pp. 2329-2341
Open Access | Times Cited: 2
Do bacterial vaccines/adjuvants prevent wheezing episodes in children?
Antonio Nieto, María Nieto, Laura Conejero, et al.
Current Opinion in Allergy and Clinical Immunology (2022) Vol. 22, Iss. 6, pp. 380-386
Closed Access | Times Cited: 2
Antonio Nieto, María Nieto, Laura Conejero, et al.
Current Opinion in Allergy and Clinical Immunology (2022) Vol. 22, Iss. 6, pp. 380-386
Closed Access | Times Cited: 2
Real-world data on the efficacy and safety of tezacaftor-ivacaftor in adults living with cystic fibrosis homozygous for F508del and heterozygous for F508del and a residual function mutation
Stefanie Vincken, Sylvia Verbanck, Sue Braun, et al.
Acta Clinica Belgica (2022) Vol. 78, Iss. 4, pp. 280-284
Closed Access | Times Cited: 1
Stefanie Vincken, Sylvia Verbanck, Sue Braun, et al.
Acta Clinica Belgica (2022) Vol. 78, Iss. 4, pp. 280-284
Closed Access | Times Cited: 1
Pan-antiviral effects of a PIKfyve inhibitor on respiratory virus infection in human nasal epithelium and mice
Jonathan Baker, Hugo Ombredane, Leah Daly, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Jonathan Baker, Hugo Ombredane, Leah Daly, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
